RecruitingPhase IIIEN originalBladder cancer

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or older. The main questions it aims to answer are: * Can the study drug help participants with this type of cancer? * Is the study drug safe? * What are the side effects of the study drug? Researchers will compare TARA-002 to chemotherapy to see if TARA-002 works to treat NMIBC.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Osoby w wieku 18 lat i starsze.
  • Osoby, u których potwierdzono raka pęcherza o wysokim stopniu złośliwości, nieinwazyjny.
  • Osoby, które wcześniej nie były leczone BCG (szczepionką przeciwgruźliczą).

✗ Disqualifies

  • Osoby z alergią na penicylinę.
  • Osoby z rakiem pęcherza moczowego, który w przeszłości naciekał na mięśnie (stopień T2 lub wyższy).
  • Osoby z przerzutami nowotworowymi.

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
June 29, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (6)

East Valley Urology Center of Arizona

Queen Creek, United States

Arkansas Urology

Little Rock, United States

Michael Oefelein Clinical Trials

Bakersfield, United States

Renown Regional Medical Center

St Louis, United States

START - Carolinas

Myrtle Beach, United States

Arensia Kapitanivka - PPDS

Kapitanivka, Ukraine

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.